Indian essential drugs list raises price control prospect but experts point to wider reform need
This article was originally published in Scrip
Executive Summary
India's recently published revised national list of essential medicines (NLEM) has raised speculation that more products face price regulation in the country, though experts say that only widespread healthcare reform will help make a material difference to access and health outcomes in the world's second most populous nation.